SEC Form 4 · accession 0001214659-16-015273
Anthera Pharmaceuticals Inc · ANTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Christopher S Henney
Director
Period of report
Dec 8, 2016
Accepted (ET)
Dec 8, 2016 · 6:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001316175
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $2.00 | Dec 8, 2016 | A | 83,910 | A | — | Dec 8, 2026 | Common Stock | 83,910 | 83,910 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments from the grant date of December 8, 2016. This stock option is fully exercisable on December 8, 2017.